Carrier Screening Market Size & Growth
The results analyzed by GME showed that the Global Carrier Screening Market will grow with a CAGR value of 17.1 percent, to hit xx billion USD by 2026. Carrier screening is a genetic test used to determine if a healthy individual is a carrier of any recessive gene or genetic disorder. It offers life-long data about the reproductive risk of a person and the likelihood of having a child with a genetic disorder. The development is expected to be driven by a rising occurrence of chromosomal anomalies and an increasing demand for carrier screening during the forecast timeline.
Browse 157 Market Data Tables and 117 Figures
spread through 189 Pages and in-depth TOC on "Carrier Screening Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-carrier-screening-market-2599
By Type (Targeted Disease Carrier Screening,
Expanded Carrier Screening), By Medical Condition (Neurological Conditions,
Pulmonary Conditions, Hematological Conditions, Other Medical Conditions), By
Technology (Microarrays, DNA Sequencing, Polymerase Chain Reaction), By
End-User (Reference Laboratories, Hospitals, Physician Offices, and Clinics,
Others), By Product & Service (Services, Products), By Region (North America, Asia
Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape,
Company Market Share Analysis & Competitor Analysis
Key Market Insights
·
The increasing
number of accredited laboratories will help the market grow tremendously from
2021 to 2026
·
As of 2020, hospitals based on the end-user will
expand the fastest with the highest value of CAGR.
·
Fulgent Genetics Inc, Sema4, Illumina
Inc., Luminex Corporation, Laboratory Corporation of America Holdings, Gene By
Gene, Invitae Corporation, Optogenetics Corporation, Asuragen, Pathway
Genomics, Eurofins Scientific, Opko Health, Quest Diagnostics Incorporated,
Myriad Genetics, Thermo Fisher Scientific Inc, Natera Inc, BGI, Progenity,
Centogene, True Health are the major players competing in this market.
Browse the
Report @ https://www.globalmarketestimates.com/market-report/global-carrier-screening-market-2599
Type Outlook (Revenue, USD Billion, 2021-2026)
·
Targeted Disease Carrier Screening
·
Expanded Carrier Screening
Medical Condition Outlook (Revenue, USD
Billion, 2021-2026)
·
Neurological Conditions
·
Pulmonary Conditions
·
Hematological Conditions
·
Other Medical Conditions
Technology Outlook (Revenue, USD Billion,
2021-2026)
·
Microarrays
·
DNA Sequencing
·
Polymerase Chain Reaction
Product & Service Outlook (Revenue, USD
Billion, 2021-2026)
·
Services
·
Products
End-User Outlook (Revenue, USD Billion,
2021-2026)
·
Reference Laboratories
·
Hospitals, Physician Offices
·
Clinics
·
Others
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central
& South America
- Brazil
- Argentina
- Rest of CSA
Middle
East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
Comments
Post a Comment